RCKT Rocket Pharmaceuticals | $12.03
+2.4% | 12/30/2024 | Initiated by | Wedbush | - | Outperform | $32.00 | N/A | View details for Wedbush rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 12/30/2024 |
AAPL Apple | $252.20
-1.3% | 12/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $300.00 -> $325.00 | N/A | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 12/26/2024 |
TCRX TScan Therapeutics | $3.00
-2.0% | 12/23/2024 | Reiterated by | Wedbush | - | Outperform | $7.00 | N/A | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 12/23/2024 |
NUVB Nuvation Bio | $2.62
-5.1% | 12/23/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 12/23/2024 |
IKNA Ikena Oncology | $1.60
+3.9% | 12/23/2024 | Reiterated by | Wedbush | - | Neutral | $2.00 | N/A | View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 12/23/2024 |
SIMO Silicon Motion Technology | $54.60
-0.5% | 12/23/2024 | Reiterated by | Wedbush | - | Outperform | $90.00 | N/A | View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 12/23/2024 |
|
BZH Beazer Homes USA | $27.34
-1.0% | 12/23/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $45.00 | N/A | View details for Wedbush rating of Beazer Homes USA (NYSE:BZH) on 12/23/2024 |
FENC Fennec Pharmaceuticals | $6.16
-1.0% | 12/20/2024 | Reiterated by | Wedbush | - | Outperform | $13.00 | N/A | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 12/20/2024 |
DRI Darden Restaurants | $186.77
-0.4% | 12/20/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $200.00 -> $220.00 | N/A | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 12/20/2024 |
XMTR Xometry | $43.88
-0.7% | 12/20/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform | $48.00 | N/A | View details for Wedbush rating of Xometry (NASDAQ:XMTR) on 12/20/2024 |
LAC Lithium Americas | C$4.29
-4.2% | 12/19/2024 | Upgraded by | Wedbush | Analyst D. Ives | Hold | | N/A | View details for Wedbush rating of Lithium Americas (TSE:LAC) on 12/19/2024 |
SNOW Snowflake | $154.97
-2.3% | 12/18/2024 | Downgraded by | Wedbush | Analyst D. Ives | Strong-Buy -> Hold | | N/A | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 12/18/2024 |
ESTC Elastic | $100.28
-1.2% | 12/18/2024 | Downgraded by | Wedbush | Analyst D. Ives | Strong-Buy -> Hold | | N/A | View details for Wedbush rating of Elastic (NYSE:ESTC) on 12/18/2024 |
VTR Ventas | $58.51
-0.6% | 12/19/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 | N/A | View details for Wedbush rating of Ventas (NYSE:VTR) on 12/19/2024 |
TRIP Tripadvisor | $14.90
+2.4% | 12/19/2024 | Reiterated by | Wedbush | - | Neutral | $17.00 | N/A | View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 12/19/2024 |
LEN Lennar | $136.20
-0.7% | 12/19/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $164.00 -> $164.00 | N/A | View details for Wedbush rating of Lennar (NYSE:LEN) on 12/19/2024 |
HMST HomeStreet | $11.23
+0.6% | 12/19/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $12.00 -> $15.00 | N/A | View details for Wedbush rating of HomeStreet (NASDAQ:HMST) on 12/19/2024 |
TTD Trade Desk | $120.17
-1.0% | 12/19/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $135.00 -> $135.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 12/19/2024 |
INOD Innodata | $42.09
-7.2% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $48.00 | N/A | View details for Wedbush rating of Innodata (NASDAQ:INOD) on 12/19/2024 |
LAC Lithium Americas | $3.00
-2.9% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Neutral | $5.00 | N/A | View details for Wedbush rating of Lithium Americas (NYSE:LAC) on 12/19/2024 |
OKLO Oklo | $23.65
+3.8% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $26.00 | N/A | View details for Wedbush rating of Oklo (NYSE:OKLO) on 12/19/2024 |
SWI SolarWinds | $14.21
-0.6% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $20.00 | N/A | View details for Wedbush rating of SolarWinds (NYSE:SWI) on 12/19/2024 |
OS Onestream | $28.87
-0.4% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $40.00 | N/A | View details for Wedbush rating of Onestream (NASDAQ:OS) on 12/19/2024 |
TXRH Texas Roadhouse | $180.19
-0.9% | 12/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $200.00 -> $200.00 | N/A | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 12/19/2024 |
MNRO Monro | $24.38
-1.5% | 12/18/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $31.00 | N/A | View details for Wedbush rating of Monro (NASDAQ:MNRO) on 12/18/2024 |
BLDR Builders FirstSource | $143.37
-1.2% | 12/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $230.00 -> $230.00 | N/A | View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 12/18/2024 |
CRM Salesforce | $335.74
-0.8% | 12/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $425.00 -> $425.00 | N/A | View details for Wedbush rating of Salesforce (NYSE:CRM) on 12/18/2024 |
MU Micron Technology | $85.31
-3.7% | 12/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $140.00 -> $140.00 | N/A | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 12/17/2024 |
CSR Centerspace | $65.15
-1.1% | 12/17/2024 | Initiated by | Wedbush | Analyst R. Anderson | Neutral | $72.00 | N/A | View details for Wedbush rating of Centerspace (NYSE:CSR) on 12/17/2024 |
GEO The GEO Group | $27.54
-0.4% | 12/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | | N/A | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 12/17/2024 |
IDYA IDEAYA Biosciences | $24.93
-0.9% | 12/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $52.00 -> $52.00 | N/A | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 12/17/2024 |
NBIX Neurocrine Biosciences | $137.06
-1.7% | 12/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $148.00 -> $148.00 | N/A | View details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 12/16/2024 |
SOUN SoundHound AI | $22.68
-5.3% | 12/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $10.00 -> $22.00 | N/A | View details for Wedbush rating of SoundHound AI (NASDAQ:SOUN) on 12/16/2024 |
HOV Hovnanian Enterprises | $133.95
+0.5% | 12/16/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $155.00 | N/A | View details for Wedbush rating of Hovnanian Enterprises (NYSE:HOV) on 12/16/2024 |
SLDB Solid Biosciences | $4.07
-4.0% | 12/12/2024 | Upgraded by | Wedbush | Analyst L. Chico | Strong-Buy | | N/A | View details for Wedbush rating of Solid Biosciences (NASDAQ:SLDB) on 12/12/2024 |
RH RH | $393.93
-1.0% | 12/13/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $430.00 -> $500.00 | N/A | View details for Wedbush rating of RH (NYSE:RH) on 12/13/2024 |
SLDB Solid Biosciences | $4.07
-4.0% | 12/13/2024 | Initiated by | Wedbush | - | Outperform | $16.00 | N/A | View details for Wedbush rating of Solid Biosciences (NASDAQ:SLDB) on 12/13/2024 |
PZZA Papa Johns International | $40.09
+1.5% | 12/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $60.00 -> $60.00 | N/A | View details for Wedbush rating of Papa Johns International (NASDAQ:PZZA) on 12/13/2024 |
ITOS iTeos Therapeutics | $7.29
-0.4% | 12/12/2024 | Reiterated by | Wedbush | - | Outperform | $25.00 | N/A | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 12/12/2024 |
TTD Trade Desk | $120.17
-1.0% | 12/12/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $135.00 -> $135.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 12/12/2024 |
⭕ [URGENT] Buy Alert just triggered (Ad) My absolute favorite stock just hit a critical "buy now" trigger price. Click here for the ticker >>> |
LEN Lennar | $136.20
-0.7% | 12/12/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $164.00 -> $164.00 | N/A | View details for Wedbush rating of Lennar (NYSE:LEN) on 12/12/2024 |
LOW Lowe's Companies | $246.73
-0.6% | 12/12/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $250.00 -> $250.00 | N/A | View details for Wedbush rating of Lowe’s Companies (NYSE:LOW) on 12/12/2024 |
ANAB AnaptysBio | $13.22
+1.4% | 12/11/2024 | Reiterated by | Wedbush | - | Outperform | $42.00 -> $40.00 | N/A | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 12/11/2024 |
DBD Diebold Nixdorf | $42.79
-0.3% | 12/11/2024 | Reiterated by | Wedbush | - | Outperform | $50.00 -> $60.00 | N/A | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 12/11/2024 |
ASO Academy Sports and Outdoors | $57.92
-3.5% | 12/11/2024 | Reiterated by | Wedbush | - | Outperform | $65.00 | N/A | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 12/11/2024 |
TOL Toll Brothers | $126.12
-0.3% | 12/11/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $175.00 | N/A | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 12/11/2024 |
VIRC Virco Mfg. | $10.21
-3.3% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $20.00 -> $17.00 | N/A | View details for Wedbush rating of Virco Mfg. (NASDAQ:VIRC) on 12/10/2024 |
CMRX Chimerix | $3.44
-0.6% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $6.00 | N/A | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 12/10/2024 |
TCRX TScan Therapeutics | $3.00
-2.0% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $10.00 -> $7.00 | N/A | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 12/10/2024 |
STRO Sutro Biopharma | $1.85
-2.1% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $8.00 | N/A | View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 12/10/2024 |
CXW CoreCivic | $21.58
+1.2% | 12/10/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $19.00 -> $30.00 | N/A | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 12/10/2024 |
TTWO Take-Two Interactive Software | $184.54
-1.0% | 12/9/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform | $190.00 | N/A | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 12/9/2024 |
VOR Vor Biopharma | $1.19
-6.3% | 12/9/2024 | Reiterated by | Wedbush | - | Outperform | $11.00 | N/A | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 12/9/2024 |
IRON Disc Medicine | $61.60
-3.9% | 12/9/2024 | Reiterated by | Wedbush | - | Outperform | $83.00 | N/A | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 12/9/2024 |
BEAM Beam Therapeutics | $25.27
-5.0% | 12/9/2024 | Reiterated by | Wedbush | - | Outperform | $57.00 | N/A | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 12/9/2024 |
EBAY eBay | $62.06
-1.2% | 12/9/2024 | Initiated by | Wedbush | Analyst S. Devitt | Neutral | $70.00 | N/A | View details for Wedbush rating of eBay (NASDAQ:EBAY) on 12/9/2024 |
WOOF Petco Health and Wellness | $3.83
-6.6% | 12/6/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5.50 -> $6.00 | N/A | View details for Wedbush rating of Petco Health and Wellness (NASDAQ:WOOF) on 12/6/2024 |
GME GameStop | $32.01
-0.6% | 12/6/2024 | Reiterated by | Wedbush | - | Underperform | $10.00 | N/A | View details for Wedbush rating of GameStop (NYSE:GME) on 12/6/2024 |
ROKU Roku | $74.89
-2.8% | 12/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $85.00 -> $100.00 | N/A | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 12/6/2024 |
ARE Alexandria Real Estate Equities | $97.80
-0.6% | 12/6/2024 | Reiterated by | Wedbush | Analyst R. Anderson | Neutral -> Outperform | $120.00 -> $110.00 | N/A | View details for Wedbush rating of Alexandria Real Estate Equities (NYSE:ARE) on 12/6/2024 |
CHWY Chewy | $34.21
+0.4% | 12/5/2024 | Reiterated by | Wedbush | - | Outperform | $35.00 -> $39.00 | N/A | View details for Wedbush rating of Chewy (NYSE:CHWY) on 12/5/2024 |
VTR Ventas | $58.51
-0.6% | 12/3/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 | N/A | View details for Wedbush rating of Ventas (NYSE:VTR) on 12/3/2024 |
ARGX argenx | $619.96
-1.0% | 12/3/2024 | Reiterated by | Wedbush | - | Outperform | $655.00 | N/A | View details for Wedbush rating of argenx (NASDAQ:ARGX) on 12/3/2024 |
CVCO Cavco Industries | $446.83
+0.8% | 12/3/2024 | Downgraded by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $480.00 -> $480.00 | N/A | View details for Wedbush rating of Cavco Industries (NASDAQ:CVCO) on 12/3/2024 |
TOL Toll Brothers | $126.12
-0.3% | 12/2/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $175.00 | N/A | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 12/2/2024 |
NVCR NovoCure | $30.08
-2.0% | 12/2/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Neutral | $24.00 -> $29.00 | N/A | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 12/2/2024 |
RVMD Revolution Medicines | $43.17
-2.4% | 12/2/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $70.00 -> $70.00 | N/A | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 12/2/2024 |
APGE Apogee Therapeutics | $44.64
-2.6% | 12/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $87.00 -> $90.00 | N/A | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 12/2/2024 |
UPST Upstart | $63.32
-6.9% | 12/2/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $60.00 -> $75.00 | N/A | View details for Wedbush rating of Upstart (NASDAQ:UPST) on 12/2/2024 |
WDC Western Digital | $59.62
-1.8% | 11/29/2024 | Reiterated by | Wedbush | - | Outperform | $95.00 | N/A | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 11/29/2024 |
AAPL Apple | $252.20
-1.3% | 11/29/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $300.00 -> $300.00 | N/A | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 11/29/2024 |
PASG Passage Bio | $0.67
+1.2% | 11/29/2024 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $3.00 -> $4.00 | N/A | View details for Wedbush rating of Passage Bio (NASDAQ:PASG) on 11/29/2024 |
VYGR Voyager Therapeutics | $5.59
-2.6% | 11/29/2024 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $7.00 -> $11.00 | N/A | View details for Wedbush rating of Voyager Therapeutics (NASDAQ:VYGR) on 11/29/2024 |
DKS DICK'S Sporting Goods | $231.74
-1.0% | 11/27/2024 | Reiterated by | Wedbush | - | Neutral | $250.00 -> $215.00 | N/A | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 11/27/2024 |
IMAX IMAX | $24.77
-1.3% | 11/27/2024 | Reiterated by | Wedbush | - | Outperform | | N/A | View details for Wedbush rating of IMAX (NYSE:IMAX) on 11/27/2024 |
SRRK Scholar Rock | $42.91
-3.5% | 11/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $40.00 -> $47.00 | N/A | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 11/25/2024 |
PLTR Palantir Technologies | $77.18
-2.4% | 11/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $57.00 -> $75.00 | N/A | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 11/25/2024 |
CRM Salesforce | $335.74
-0.8% | 11/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $325.00 -> $375.00 | N/A | View details for Wedbush rating of Salesforce (NYSE:CRM) on 11/25/2024 |
SNOW Snowflake | $154.97
-2.3% | 11/25/2024 | Upgraded by | Wedbush | Analyst D. Ives | Neutral -> Outperform | $190.00 | N/A | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 11/25/2024 |
ESTC Elastic | $100.28
-1.2% | 11/25/2024 | Upgraded by | Wedbush | Analyst D. Ives | Neutral -> Outperform | $135.00 | N/A | View details for Wedbush rating of Elastic (NYSE:ESTC) on 11/25/2024 |
NTAP NetApp | $116.49
-0.4% | 11/22/2024 | Reiterated by | Wedbush | - | Neutral | $120.00 | N/A | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 11/22/2024 |
CATX Perspective Therapeutics | $3.06
-4.1% | 11/21/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $20.00 -> $11.00 | N/A | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 11/21/2024 |
NVDA NVIDIA | $137.49
+0.4% | 11/21/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $160.00 -> $175.00 | N/A | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 11/21/2024 |
WSM Williams-Sonoma | $186.51
+0.2% | 11/21/2024 | Target Raised by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $135.00 -> $175.00 | N/A | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 11/21/2024 |
SNOW Snowflake | $154.97
-2.3% | 11/21/2024 | Target Raised by | Wedbush | Analyst D. Ives | Neutral -> Neutral | $130.00 -> $160.00 | N/A | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 11/21/2024 |
MSFT Microsoft | $424.83
-1.3% | 11/19/2024 | Reiterated by | Wedbush | Analyst D. Ives | Outperform | $550.00 | N/A | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 11/19/2024 |
FTNT Fortinet | $95.13
-1.0% | 11/19/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $90.00 -> $105.00 | N/A | View details for Wedbush rating of Fortinet (NASDAQ:FTNT) on 11/19/2024 |
PTGX Protagonist Therapeutics | $38.51
-1.2% | 11/19/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $58.00 | N/A | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 11/19/2024 |
ORKA Oruka Therapeutics | $18.95
-0.3% | 11/19/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $40.00 | N/A | View details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 11/19/2024 |
NFLX Netflix | $900.43
-0.8% | 11/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $800.00 -> $950.00 | N/A | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 11/18/2024 |
⭕ [URGENT] Buy Alert just triggered (Ad) My absolute favorite stock just hit a critical "buy now" trigger price. Click here for the ticker >>> |
SWTX SpringWorks Therapeutics | $36.34
0.0% | 11/18/2024 | Reiterated by | Wedbush | - | Outperform | $77.00 | N/A | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/18/2024 |
JACK Jack in the Box | $42.30
-0.2% | 11/18/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $60.00 -> $50.00 | N/A | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 11/18/2024 |
NTLA Intellia Therapeutics | $11.41
-4.7% | 11/18/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $14.00 -> $14.00 | N/A | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/18/2024 |
TSLA Tesla | $417.41
-3.3% | 11/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $400.00 -> $400.00 | N/A | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 11/18/2024 |
CMRX Chimerix | $3.44
-0.6% | 11/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 -> $6.00 | N/A | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 11/18/2024 |
AAP Advance Auto Parts | $46.05
+4.5% | 11/15/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $55.00 -> $55.00 | N/A | View details for Wedbush rating of Advance Auto Parts (NYSE:AAP) on 11/15/2024 |
ASND Ascendis Pharma A/S | $136.48
-0.7% | 11/15/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform -> Outperform | $181.00 -> $181.00 | N/A | View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/15/2024 |
DIN Dine Brands Global | $30.41
-0.8% | 11/15/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $47.00 -> $47.00 | N/A | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 11/15/2024 |
BPMC Blueprint Medicines | $86.82
-2.9% | 11/14/2024 | Reiterated by | Wedbush | - | Outperform | $135.00 | N/A | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 11/14/2024 |
ANAB AnaptysBio | $13.22
+1.4% | 11/14/2024 | Reiterated by | Wedbush | - | Outperform | $42.00 | N/A | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 11/14/2024 |
CAKE Cheesecake Factory | $47.37
-1.3% | 11/14/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $52.00 -> $59.00 | N/A | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 11/14/2024 |
NVDA NVIDIA | $137.49
+0.4% | 11/14/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $138.00 -> $160.00 | N/A | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 11/14/2024 |
RUM Rumble | $13.84
-9.1% | 11/13/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Neutral | $8.00 | N/A | View details for Wedbush rating of Rumble (NASDAQ:RUM) on 11/13/2024 |
RKT Rocket Companies | $11.03
-0.6% | 11/13/2024 | Reiterated by | Wedbush | - | Neutral | $18.00 -> $13.00 | N/A | View details for Wedbush rating of Rocket Companies (NYSE:RKT) on 11/13/2024 |
CAVA CAVA Group | $111.52
-2.5% | 11/13/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $155.00 -> $190.00 | N/A | View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 11/13/2024 |
FATE Fate Therapeutics | $1.62
+0.6% | 11/12/2024 | Reiterated by | Wedbush | - | Neutral | $5.00 | N/A | View details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 11/12/2024 |
SHOP Shopify | $106.69
-1.4% | 11/12/2024 | Reiterated by | Wedbush | - | Neutral | $72.00 -> $115.00 | N/A | View details for Wedbush rating of Shopify (NYSE:SHOP) on 11/12/2024 |
SDHC Smith Douglas Homes | $25.99
-2.8% | 11/12/2024 | Reiterated by | Wedbush | - | Neutral | $20.00 | N/A | View details for Wedbush rating of Smith Douglas Homes (NYSE:SDHC) on 11/12/2024 |
APGE Apogee Therapeutics | $44.64
-2.6% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $87.00 | N/A | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 11/12/2024 |
ITOS iTeos Therapeutics | $7.29
-0.4% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $25.00 | N/A | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 11/12/2024 |
IRON Disc Medicine | $61.60
-3.9% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 -> $83.00 | N/A | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 11/12/2024 |
COGT Cogent Biosciences | $7.71
-0.4% | 11/12/2024 | Reiterated by | Wedbush | - | Neutral | $11.00 | N/A | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 11/12/2024 |
ORIC ORIC Pharmaceuticals | $8.17
-1.0% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $20.00 | N/A | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 11/12/2024 |
NUVL Nuvalent | $77.87
-3.0% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $115.00 | N/A | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 11/12/2024 |
DDI DoubleDown Interactive | $10.55
+2.9% | 11/12/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $16.25 -> $21.00 | N/A | View details for Wedbush rating of DoubleDown Interactive (NASDAQ:DDI) on 11/12/2024 |
PINS Pinterest | $29.15
-1.4% | 11/11/2024 | Upgraded by | Wedbush | Analyst S. Devitt | Hold -> Strong-Buy | | N/A | View details for Wedbush rating of Pinterest (NYSE:PINS) on 11/11/2024 |
TSLA Tesla | $417.41
-3.3% | 11/11/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $300.00 -> $400.00 | N/A | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 11/11/2024 |
STKS ONE Group Hospitality | $2.94
+1.0% | 11/11/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $5.00 -> $3.50 | N/A | View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 11/11/2024 |
VOR Vor Biopharma | $1.19
-6.3% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform | $11.00 | N/A | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 11/8/2024 |
SYRE Spyre Therapeutics | $22.54
-4.8% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform | $45.00 | N/A | View details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 11/8/2024 |
CAKE Cheesecake Factory | $47.37
-1.3% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $52.00 -> $52.00 | N/A | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 11/8/2024 |
EXPE Expedia Group | $186.49
+0.2% | 11/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $130.00 -> $180.00 | N/A | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 11/8/2024 |
RIVN Rivian Automotive | $13.58
-0.5% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $20.00 -> $20.00 | N/A | View details for Wedbush rating of Rivian Automotive (NASDAQ:RIVN) on 11/8/2024 |
RNG RingCentral | $35.46
-1.8% | 11/8/2024 | Target Raised by | Wedbush | Analyst D. Ives | Neutral -> Neutral | $36.00 -> $41.00 | N/A | View details for Wedbush rating of RingCentral (NYSE:RNG) on 11/8/2024 |
CCSI Consensus Cloud Solutions | $23.73
-0.8% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $24.00 -> $32.00 | N/A | View details for Wedbush rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 11/8/2024 |
ABNB Airbnb | $131.81
-1.2% | 11/8/2024 | Target Raised by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $135.00 -> $155.00 | N/A | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 11/8/2024 |
PINS Pinterest | $29.15
-1.4% | 11/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $37.00 -> $38.00 | N/A | View details for Wedbush rating of Pinterest (NYSE:PINS) on 11/8/2024 |
TOST Toast | $36.88
-1.7% | 11/8/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $35.00 -> $45.00 | N/A | View details for Wedbush rating of Toast (NYSE:TOST) on 11/8/2024 |
RDFN Redfin | $7.94
-3.2% | 11/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $8.00 -> $10.00 | N/A | View details for Wedbush rating of Redfin (NASDAQ:RDFN) on 11/8/2024 |
TTD Trade Desk | $120.17
-1.0% | 11/8/2024 | Target Raised by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $115.00 -> $135.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 11/8/2024 |
FTNT Fortinet | $95.13
-1.0% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $78.00 -> $90.00 | N/A | View details for Wedbush rating of Fortinet (NASDAQ:FTNT) on 11/8/2024 |
VERA Vera Therapeutics | $42.06
+1.6% | 11/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $30.00 -> $38.00 | N/A | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 11/8/2024 |
GEO The GEO Group | $27.54
-0.4% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $25.00 -> $30.00 | N/A | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 11/8/2024 |
UPST Upstart | $63.32
-6.9% | 11/8/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $45.00 -> $60.00 | N/A | View details for Wedbush rating of Upstart (NASDAQ:UPST) on 11/8/2024 |
PEPG PepGen | $3.83
-2.3% | 11/8/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $19.00 -> $12.00 | N/A | View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 11/8/2024 |
VIGL Vigil Neuroscience | $1.53
-7.3% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $23.00 -> $24.00 | N/A | View details for Wedbush rating of Vigil Neuroscience (NASDAQ:VIGL) on 11/8/2024 |
EWTX Edgewise Therapeutics | $27.06
-5.8% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $44.00 -> $45.00 | N/A | View details for Wedbush rating of Edgewise Therapeutics (NASDAQ:EWTX) on 11/8/2024 |
TPX Tempur Sealy International | $56.98
+3.5% | 11/8/2024 | Target Raised by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $49.00 -> $55.00 | N/A | View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 11/8/2024 |
ARHS Arhaus | $9.28
+0.2% | 11/8/2024 | Target Lowered by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $11.00 -> $10.00 | N/A | View details for Wedbush rating of Arhaus (NASDAQ:ARHS) on 11/8/2024 |
PZZA Papa Johns International | $40.09
+1.5% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $60.00 -> $60.00 | N/A | View details for Wedbush rating of Papa Johns International (NASDAQ:PZZA) on 11/8/2024 |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
GLUE Monte Rosa Therapeutics | $7.02
-0.6% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | N/A | View details for Wedbush rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 11/7/2024 |
ACET Adicet Bio | $0.90
-2.8% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 11/7/2024 |
YOU Clear Secure | $27.07
-0.6% | 11/7/2024 | Reiterated by | Wedbush | - | Neutral | $24.00 -> $26.00 | N/A | View details for Wedbush rating of Clear Secure (NYSE:YOU) on 11/7/2024 |
TRIP Tripadvisor | $14.90
+2.4% | 11/7/2024 | Reiterated by | Wedbush | - | Neutral | $16.00 -> $17.00 | N/A | View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 11/7/2024 |
CMRX Chimerix | $3.44
-0.6% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $6.00 | N/A | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 11/7/2024 |
IKNA Ikena Oncology | $1.60
+3.9% | 11/7/2024 | Reiterated by | Wedbush | - | Neutral | $2.00 | N/A | View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 11/7/2024 |
NTLA Intellia Therapeutics | $11.41
-4.7% | 11/7/2024 | Reiterated by | Wedbush | - | Neutral | $14.00 | N/A | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/7/2024 |
FENC Fennec Pharmaceuticals | $6.16
-1.0% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $14.00 -> $13.00 | N/A | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 11/7/2024 |
RCUS Arcus Biosciences | $14.91
-2.4% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $36.00 | N/A | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 11/7/2024 |
SWTX SpringWorks Therapeutics | $36.34
0.0% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $77.00 | N/A | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/7/2024 |
GBIO Generation Bio | $1.06
-0.9% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Generation Bio (NASDAQ:GBIO) on 11/7/2024 |
TTWO Take-Two Interactive Software | $184.54
-1.0% | 11/7/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform | $190.00 | N/A | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 11/7/2024 |
RITM Rithm Capital | $10.87
-0.5% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $14.00 | N/A | View details for Wedbush rating of Rithm Capital (NYSE:RITM) on 11/7/2024 |
GHLD Guild | $14.18
+1.2% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $20.00 | N/A | View details for Wedbush rating of Guild (NYSE:GHLD) on 11/7/2024 |
XNCR Xencor | $23.71
-2.4% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $38.00 | N/A | View details for Wedbush rating of Xencor (NASDAQ:XNCR) on 11/7/2024 |
MFA MFA Financial | $10.22
-2.0% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | N/A | View details for Wedbush rating of MFA Financial (NYSE:MFA) on 11/7/2024 |
KROS Keros Therapeutics | $15.64
-4.8% | 11/7/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $84.00 | N/A | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 11/7/2024 |
NUVB Nuvation Bio | $2.62
-5.1% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 11/7/2024 |
MELI MercadoLibre | $1,721.80
-0.2% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $2,000.00 -> $2,200.00 | N/A | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 11/7/2024 |
APP AppLovin | $335.38
+0.1% | 11/7/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform | $170.00 -> $270.00 | N/A | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 11/7/2024 |
LYFT Lyft | $13.05
-2.0% | 11/7/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Neutral | $12.00 -> $20.00 | N/A | View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 11/7/2024 |
BROS Dutch Bros | $52.55
-1.5% | 11/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $45.00 -> $55.00 | N/A | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 11/7/2024 |
DIN Dine Brands Global | $30.41
-0.8% | 11/7/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $47.00 -> $47.00 | N/A | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 11/7/2024 |
ANAB AnaptysBio | $13.22
+1.4% | 11/6/2024 | Reiterated by | Wedbush | - | Outperform | $42.00 | N/A | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 11/6/2024 |
BLDR Builders FirstSource | $143.37
-1.2% | 11/6/2024 | Reiterated by | Wedbush | - | Outperform | $230.00 | N/A | View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 11/6/2024 |
LGIH LGI Homes | $88.68
-1.0% | 11/6/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $125.00 | N/A | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 11/6/2024 |
GPRO GoPro | $1.12
+0.9% | 11/6/2024 | Reiterated by | Wedbush | - | Neutral | $1.50 | N/A | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 11/6/2024 |
MLTX MoonLake Immunotherapeutics | $53.02
-4.2% | 11/4/2024 | Upgraded by | Wedbush | Analyst Y. Zhong | Strong-Buy | | Low | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/4/2024 |
KROS Keros Therapeutics | $15.64
-4.8% | 11/4/2024 | Upgraded by | Wedbush | Analyst Y. Zhong | Strong-Buy | | Low | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 11/4/2024 |
BMRN BioMarin Pharmaceutical | $65.45
-2.2% | 11/4/2024 | Upgraded by | Wedbush | Analyst Y. Zhong | Strong-Buy | | Low | View details for Wedbush rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 11/4/2024 |
ASND Ascendis Pharma A/S | $136.48
-0.7% | 11/4/2024 | Upgraded by | Wedbush | Analyst Y. Zhong | Strong-Buy | | Low | View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/4/2024 |
GFS GlobalFoundries | $43.20
-2.2% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $65.00 -> $60.00 | High | View details for Wedbush rating of GlobalFoundries (NASDAQ:GFS) on 11/5/2024 |
INZY Inozyme Pharma | $2.82
-3.4% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 -> $12.00 | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 11/5/2024 |
BEAM Beam Therapeutics | $25.27
-5.0% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $57.00 | High | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 11/5/2024 |
TCRX TScan Therapeutics | $3.00
-2.0% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $10.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 11/5/2024 |
WING Wingstop | $287.16
+0.6% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $390.00 -> $390.00 | Low | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 11/5/2024 |
CRSR Corsair Gaming | $6.60
+0.8% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $11.00 -> $11.00 | Low | View details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 11/5/2024 |
HEAR Turtle Beach | $17.09
+1.0% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $19.00 -> $19.00 | N/A | View details for Wedbush rating of Turtle Beach (NASDAQ:HEAR) on 11/5/2024 |
MLTX MoonLake Immunotherapeutics | $53.02
-4.2% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $92.00 -> $73.00 | Medium | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/5/2024 |
HMST HomeStreet | $11.23
+0.6% | 11/5/2024 | Upgraded by | Wedbush | Analyst D. Chiaverini | Neutral -> Outperform | $12.00 | High | View details for Wedbush rating of HomeStreet (NASDAQ:HMST) on 11/5/2024 |
APP AppLovin | $335.38
+0.1% | 11/4/2024 | Upgraded by | Wedbush | Analyst M. Pachter | Strong-Buy | | High | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 11/4/2024 |
IDYA IDEAYA Biosciences | $24.93
-0.9% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $52.00 | Medium | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 11/4/2024 |
SE SEA | $107.48
-1.1% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $84.00 -> $105.00 | Low | View details for Wedbush rating of SEA (NYSE:SE) on 11/4/2024 |
SAFE Safehold | $18.34
-1.6% | 11/4/2024 | Reiterated by | Wedbush | - | Neutral | $25.00 -> $23.00 | Medium | View details for Wedbush rating of Safehold (NYSE:SAFE) on 11/4/2024 |
WLDN Willdan Group | $38.36
-0.1% | 11/4/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $51.00 | Medium | View details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 11/4/2024 |
NCMI National CineMedia | $6.47
-2.1% | 11/4/2024 | Reiterated by | Wedbush | - | Neutral | $6.00 -> $7.50 | High | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 11/4/2024 |
SRRK Scholar Rock | $42.91
-3.5% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $37.00 | High | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 11/4/2024 |
CRBP Corbus Pharmaceuticals | $12.08
-5.3% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $51.00 | Medium | View details for Wedbush rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 11/4/2024 |
IRON Disc Medicine | $61.60
-3.9% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $60.00 -> $75.00 | High | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 11/4/2024 |
KURA Kura Oncology | $8.51
-1.8% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $37.00 | Low | View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 11/4/2024 |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
RZLT Rezolute | $4.89
-1.4% | 11/4/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $112.00 | Low | View details for Wedbush rating of Rezolute (NASDAQ:RZLT) on 11/4/2024 |
PTGX Protagonist Therapeutics | $38.51
-1.2% | 11/4/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $58.00 | High | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 11/4/2024 |
W Wayfair | $44.62
+2.0% | 11/4/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $50.00 -> $45.00 | Low | View details for Wedbush rating of Wayfair (NYSE:W) on 11/4/2024 |
UFPI UFP Industries | $112.19
0.0% | 11/4/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $155.00 | Low | View details for Wedbush rating of UFP Industries (NASDAQ:UFPI) on 11/4/2024 |
SMCI Super Micro Computer | $30.68
-4.1% | 11/4/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $62.00 -> $32.00 | Medium | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 11/4/2024 |
DBD Diebold Nixdorf | $42.79
-0.3% | 11/4/2024 | Reiterated by | Wedbush | Analyst M. Bryson | Outperform | $50.00 | Low | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 11/4/2024 |
MHO M/I Homes | $132.44
-1.1% | 11/4/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $155.00 -> $185.00 | Medium | View details for Wedbush rating of M/I Homes (NYSE:MHO) on 11/4/2024 |
CNK Cinemark | $30.97
+0.1% | 11/1/2024 | Downgraded by | Wedbush | Analyst A. Reese | Strong-Buy -> Hold | | Medium | View details for Wedbush rating of Cinemark (NYSE:CNK) on 11/1/2024 |
AMZN Amazon.com | $221.30
-1.1% | 11/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $225.00 -> $250.00 | Low | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 11/1/2024 |
BJRI BJ's Restaurants | $34.82
+0.2% | 11/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $43.00 -> $43.00 | High | View details for Wedbush rating of BJ’s Restaurants (NASDAQ:BJRI) on 11/1/2024 |
WEN Wendy's | $16.26
-1.5% | 11/1/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $20.00 -> $20.00 | Medium | View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 11/1/2024 |
SBUX Starbucks | $90.58
-1.8% | 10/31/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $98.00 -> $95.00 | Low | View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 10/31/2024 |
CMG Chipotle Mexican Grill | $60.09
-1.1% | 10/30/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $69.00 -> $69.00 | Low | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 10/30/2024 |
CAKE Cheesecake Factory | $47.37
-1.3% | 10/30/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $48.00 -> $52.00 | High | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 10/30/2024 |
WSM Williams-Sonoma | $186.51
+0.2% | 10/30/2024 | Downgraded by | Wedbush | Analyst S. Basham | Outperform -> Neutral | $150.00 -> $135.00 | Medium | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 10/30/2024 |
CNK Cinemark | $30.97
+0.1% | 10/29/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $31.00 -> $32.00 | Low | View details for Wedbush rating of Cinemark (NYSE:CNK) on 10/29/2024 |
W Wayfair | $44.62
+2.0% | 10/28/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $60.00 -> $50.00 | Medium | View details for Wedbush rating of Wayfair (NYSE:W) on 10/28/2024 |
TXRH Texas Roadhouse | $180.19
-0.9% | 10/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $190.00 -> $200.00 | Low | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 10/25/2024 |
PEGA Pegasystems | $93.29
-1.2% | 10/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $90.00 -> $100.00 | Low | View details for Wedbush rating of Pegasystems (NASDAQ:PEGA) on 10/25/2024 |
BKNG Booking | $4,990.87
-0.9% | 10/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $3,900.00 -> $4,750.00 | Low | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 10/25/2024 |
FND Floor & Decor | $99.89
0.0% | 10/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $110.00 -> $110.00 | Medium | View details for Wedbush rating of Floor & Decor (NYSE:FND) on 10/25/2024 |
WDC Western Digital | $59.62
-1.8% | 10/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $95.00 -> $95.00 | High | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 10/25/2024 |
TSCO Tractor Supply | $52.59
-3.6% | 10/25/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $54.00 -> $54.00 | Low | View details for Wedbush rating of Tractor Supply (NASDAQ:TSCO) on 10/25/2024 |
TYRA Tyra Biosciences | $13.90
-1.2% | 10/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $28.00 -> $28.00 | High | View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 10/25/2024 |
IMNM Immunome | $10.28
-2.5% | 10/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $33.00 -> $33.00 | High | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 10/25/2024 |
APGE Apogee Therapeutics | $44.64
-2.6% | 10/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $87.00 -> $87.00 | Low | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 10/25/2024 |
ROKU Roku | $74.89
-2.8% | 10/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $75.00 -> $85.00 | Low | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 10/25/2024 |
BYON Beyond | $4.86
+5.2% | 10/25/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $25.00 -> $15.00 | Low | View details for Wedbush rating of Beyond (NYSE:BYON) on 10/25/2024 |
EA Electronic Arts | $146.54
-1.1% | 10/25/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform -> Outperform | $170.00 -> $170.00 | Low | View details for Wedbush rating of Electronic Arts (NASDAQ:EA) on 10/25/2024 |
RBLX Roblox | $58.48
-1.6% | 10/25/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform -> Outperform | $49.00 -> $49.00 | Low | View details for Wedbush rating of Roblox (NYSE:RBLX) on 10/25/2024 |
EGP EastGroup Properties | $161.13
-0.1% | 10/25/2024 | Reiterated by | Wedbush | Analyst R. Anderson | Outperform -> Outperform | $209.00 -> $209.00 | Medium | View details for Wedbush rating of EastGroup Properties (NYSE:EGP) on 10/25/2024 |
FCNCA First Citizens BancShares | $2,112.93
-0.9% | 10/25/2024 | Target Lowered by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $2,150.00 -> $2,000.00 | Low | View details for Wedbush rating of First Citizens BancShares (NASDAQ:FCNCA) on 10/25/2024 |
COLB Columbia Banking System | $26.94
-0.7% | 10/25/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $31.00 -> $35.00 | Medium | View details for Wedbush rating of Columbia Banking System (NASDAQ:COLB) on 10/25/2024 |
VLY Valley National Bancorp | $9.12
| 10/25/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $10.00 -> $10.00 | High | View details for Wedbush rating of Valley National Bancorp (NASDAQ:VLY) on 10/25/2024 |
PPBI Pacific Premier Bancorp | $24.73
| 10/25/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $27.00 -> $25.00 | Medium | View details for Wedbush rating of Pacific Premier Bancorp (NASDAQ:PPBI) on 10/25/2024 |
TOL Toll Brothers | $126.12
-0.3% | 10/25/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $148.00 -> $175.00 | Medium | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 10/25/2024 |
TMHC Taylor Morrison Home | $61.10
+0.8% | 10/25/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $65.00 -> $85.00 | Low | View details for Wedbush rating of Taylor Morrison Home (NYSE:TMHC) on 10/25/2024 |
COOP Mr. Cooper Group | $94.77
+0.5% | 10/24/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $115.00 -> $115.00 | Medium | View details for Wedbush rating of Mr. Cooper Group (NASDAQ:COOP) on 10/24/2024 |
PMT PennyMac Mortgage Investment Trust | $12.44
-0.9% | 10/24/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $15.00 -> $15.00 | Low | View details for Wedbush rating of PennyMac Mortgage Investment Trust (NYSE:PMT) on 10/24/2024 |
TSLA Tesla | $417.41
-3.3% | 10/24/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $300.00 -> $300.00 | High | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 10/24/2024 |
SLM SLM | $27.55
-1.1% | 10/24/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $26.00 -> $26.00 | High | View details for Wedbush rating of SLM (NASDAQ:SLM) on 10/24/2024 |
PB Prosperity Bancshares | $75.14
-0.4% | 10/24/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $90.00 -> $90.00 | Low | View details for Wedbush rating of Prosperity Bancshares (NYSE:PB) on 10/24/2024 |
LC LendingClub | $16.41
-1.8% | 10/24/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $14.00 -> $17.00 | High | View details for Wedbush rating of LendingClub (NYSE:LC) on 10/24/2024 |
CVBF CVB Financial | $21.71
-1.1% | 10/24/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $20.00 -> $20.00 | High | View details for Wedbush rating of CVB Financial (NASDAQ:CVBF) on 10/24/2024 |
GOOGL Alphabet | $191.24
-0.8% | 10/24/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $205.00 -> $205.00 | Low | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 10/24/2024 |
ORLY O'Reilly Automotive | $1,179.92
-1.5% | 10/24/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $1,200.00 -> $1,200.00 | Medium | View details for Wedbush rating of O’Reilly Automotive (NASDAQ:ORLY) on 10/24/2024 |
TPH Tri Pointe Homes | $36.28
+0.2% | 10/24/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $42.00 -> $42.00 | High | View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 10/24/2024 |
CCS Century Communities | $72.88
-1.0% | 10/24/2024 | Target Raised by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $90.00 -> $96.00 | High | View details for Wedbush rating of Century Communities (NYSE:CCS) on 10/24/2024 |
CATX Perspective Therapeutics | $3.06
-4.1% | 10/24/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform -> Outperform | $20.00 -> $20.00 | Low | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 10/24/2024 |
PFSI PennyMac Financial Services | $101.38
-0.7% | 10/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $130.00 -> $130.00 | High | View details for Wedbush rating of PennyMac Financial Services (NYSE:PFSI) on 10/23/2024 |
HAFC Hanmi Financial | $23.48
+0.4% | 10/23/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $21.00 -> $21.00 | Medium | View details for Wedbush rating of Hanmi Financial (NASDAQ:HAFC) on 10/23/2024 |
EWBC East West Bancorp | $96.28
-0.4% | 10/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $100.00 -> $110.00 | High | View details for Wedbush rating of East West Bancorp (NASDAQ:EWBC) on 10/23/2024 |
LOGI Logitech International | $82.64
-0.9% | 10/23/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $88.00 -> $88.00 | Low | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 10/23/2024 |
CATY Cathay General Bancorp | $47.72
-0.7% | 10/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $50.00 -> $52.00 | Medium | View details for Wedbush rating of Cathay General Bancorp (NASDAQ:CATY) on 10/23/2024 |
BANC Banc of California | $15.57
+0.4% | 10/23/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $18.00 -> $19.00 | Medium | View details for Wedbush rating of Banc of California (NYSE:BANC) on 10/23/2024 |
GM General Motors | $53.66
-1.1% | 10/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $55.00 -> $60.00 | Low | View details for Wedbush rating of General Motors (NYSE:GM) on 10/23/2024 |
STX Seagate Technology | $86.53
-1.0% | 10/23/2024 | Reiterated by | Wedbush | Analyst M. Bryson | Outperform -> Outperform | $150.00 -> $150.00 | High | View details for Wedbush rating of Seagate Technology (NASDAQ:STX) on 10/23/2024 |
TMHC Taylor Morrison Home | $61.10
+0.8% | 10/23/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $65.00 -> $65.00 | Low | View details for Wedbush rating of Taylor Morrison Home (NYSE:TMHC) on 10/23/2024 |
GPC Genuine Parts | $115.82
-1.0% | 10/23/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $145.00 -> $120.00 | Low | View details for Wedbush rating of Genuine Parts (NYSE:GPC) on 10/23/2024 |
ARE Alexandria Real Estate Equities | $97.80
-0.6% | 10/23/2024 | Target Lowered by | Wedbush | Analyst R. Anderson | Neutral -> Neutral | $130.00 -> $120.00 | Low | View details for Wedbush rating of Alexandria Real Estate Equities (NYSE:ARE) on 10/23/2024 |
